Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06796374 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Comparison of Fisetin Kinetics in Young and Old Adults

Study acronym: FISEKIN-1
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Recruitingv2 Show 8 more changesShow less
    • Primary completion date: Jun 30, 2026 to Jun 30, 2027
    • Start date: Feb 1, 2025 to Mar 31, 2026
    • Study sites: 0 to 1
    • Study completion date: Jul 31, 2026 to Jul 31, 2027
    • Interventions: Fisetin (Dietary Supplement), Fisetin + Quercetin (Dietary Supplement) to Fisetin - Fasted condition (Dietary Supplement), Fisetin - Fed condition (Dietary Supplement)
    • Eligibility criteria expanded, about 40 words
    • Secondary endpoints: 30 to 24
    • Study description expanded, about 62 words
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study investigates the differences in the kinetic parameters of fisetin in two cohorts of healthy volunteers: Cohort 1) volunteers aged 18-30 years (n = 40) Cohort 2) volunteers aged 65 years or older (n = 40) The purpose of this study is: 1. To describe the fisetin kinetics after a single dose oral administration in older age. 2. To compare the fisetin kinetics after a single dose oral administration in old and young age. FISEKIN-1 is designed as a four-arm study protocol. As well as two different age groups (18-30 years vs. 65 years and older), we want to compare fisetin kinetic parameters in fasted and fed condition: Arm 1) 500 mg fisetin (1x 5 capsule), fasted condition, cohort 1: young age Arm 2) 500 mg fisetin (1x 5 capsule), fasted condition, cohort 2: old age Arm 3) 500 mg fisetin (1x 5 capsule), fed condition, cohort 1: young age Arm 4) 500 mg fisetin (1x 5 capsule), fed condition, cohort 2: old age
Trial Details
NCT Number NCT06796374
Lead Sponsor University Medicine Greifswald
Conditions
(from sponsor)		 Pharmacokinetic Study in Healthy Volunteers
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov